OCULAR SURFACE STEM CELL TRANSPLANT REJECTION

This adverse event was reported 9 times

OCULAR SURFACE STEM CELL TRANSPLANT REJECTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DIFLUPREDNATE OPHTHALMIC 2 0.0023
1 DIFLUPREDNATE 2 0.0005
2 NORTRIPTYLINE HYDROCHLORIDE 1 0.0002
3 DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE 1 0.0001
4 PREDNISOLONE ACETATE 1 0.0001
5 TOBRAMYCIN SOLUTION 1 0.0001
6 TOBRAMYCIN SULFATE 1 0.0001
7 CENEGERMIN-BKBJ 1 0.0001
8 TACROLIMUS OINTMENT 0.1% 8 0.0001
9 TACROLIMUS EXTENDED-RELEASE CAPSULES 8 0.0001
See all drugs enriched for association with OCULAR SURFACE STEM CELL TRANSPLANT REJECTION

OCULAR SURFACE STEM CELL TRANSPLANT REJECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Recombinant Human Nerve Growth Factor [EPC] 1 0.0001
1 Aminoglycoside Antibacterial [EPC] 1 0.0000
2 Purine Antimetabolite [EPC] 1 0.0000
3 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
4 Corticosteroid [EPC] 8 0.0000
See all drug classes enriched for association with OCULAR SURFACE STEM CELL TRANSPLANT REJECTION